United States v. Wallace

597 F.3d 794, 2010 U.S. App. LEXIS 5357, 2010 WL 910103
CourtCourt of Appeals for the Sixth Circuit
DecidedMarch 16, 2010
Docket07-2230
StatusPublished
Cited by205 cases

This text of 597 F.3d 794 (United States v. Wallace) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Wallace, 597 F.3d 794, 2010 U.S. App. LEXIS 5357, 2010 WL 910103 (6th Cir. 2010).

Opinions

CLAY, J., delivered the opinion of the court, in which MERRITT, J., joined, and also filed a separate concurring opinion (p. 808). McKEAGUE, J. (pp. 808-12), delivered a separate opinion concurring in part and dissenting in part.

OPINION

CLAY, Circuit Judge.

Defendant Barbara Wallace appeals her conviction and sentence following her conviction for perjury in violation of 18 U.S.C. § 1621, conspiracy to possess with intent to distribute oxycodone (OxyContin) in violation of 21 U.S.C. § 841(a)(1), and use of a communication facility to facilitate a drug crime in violation of 21 U.S.C. § 843(b). She appeals challenging both her conviction and the procedural reasonableness of her sentence. For the following reasons, Wallace’s conviction is AFFIRMED, but her sentence is VACATED, and the case is REMANDED for re-sentencing.

BACKGROUND

Wallace has been tried twice on the drug charges. A first trial ended in mistrial when the jury could not reach a unanimous verdict. A new indictment was filed adding two counts of perjury based on Wallace’s testimony at the first trial. The perjury and drug charges were tried together at a second trial where Wallace was found guilty of all charges. She was given concurrent sentences, the longest of which was seventy-eight months.

Wallace came to the attention of authorities following an investigation that began in Saginaw, Michigan. Federal authorities were suspicious of a series of packages sent to a “Kim Smith” in Saginaw from addresses in California that did not exist. A package was intercepted in October 2004, and a drug detection dog picked the package out of a package “line up.” The postal inspector opened the package and found sixty tablets of OxyContin. In connection with the delivery of this package, a search warrant was executed which revealed that the intended recipient was Wardell Amos. Upon further investigation, it was determined that the addressed re[797]*797cipient, “Kim Smith,” did not exist. Amos agreed to cooperate with the government and placed a phone call to Wallace’s home.

During the investigation, Drug Enforcement Agency (“DEA”) agents found copies of six Express Mail packages of similar weight sent from California to “Kim Smith.” One of the packages identified on the return address a Jean Wallace of 435 East 84th Place, Los Angeles, California. Wallace’s mother’s address was 433 East 84th Place in Los Angeles. The defendant’s middle name is Jean. Security cameras at the post office in Los Angeles showed Wallace and her boyfriend Dameon White-Baber entering the post office and showed Wallace filling out the mailing label. The package included a doll that Wallace later claimed she was sending to a relative of White-Baber. The OxyContin was inside the packaging for the doll. The parties stipulated that Wallace completed the Express Mail label for packages mailed on May 28, 2004 and October 20, 2004, while White-Baber completed the labels for other packages sent to Amos’ address. Wallace testified at her first trial that White-Baber’s family referred to her as “Jean.”

Additionally, on August 26, 2004, Wallace and White-Baber went to a Western Union Office to cash a five hundred dollar money order in Wallace’s name. At her initial trial, Wallace testified that she did not end up with any of the cash. At the second trial, the Western Union clerk testified that office policy would have been to hand the money to Wallace, since the wire was in her name, and she signed for it. At the second trial, Wallace clarified that she did not remember whether the money was initially handed to her but insisted that White-Baber ended up with it eventually.

Wallace was charged on August 24, 2005 with a four-count indictment for conspiracy to possess with intent to distribute and to distribute OxyContin in violation of 21 U.S.C. § 841(a)(1) and misuse of a communications facility in connection with a drug offense in violation of 21 U.S.C. § 843(b). Wallace was added to a previous indictment that had included Wardell Amos and Dameon White-Baber. A Fifth Superceding Indictment removed Amos from the indictment, following his plea, and added a second count against Wallace for use of a communication facility to commit a drug crime in violation of 21 U.S.C. § 843(b).

The first trial commenced on December 5, 2006 and continued until December 13, 2006, when a mistrial was declared because the jury could not reach an unanimous verdict. On February 28, 2007, a Sixth Superceding Indictment was issued only against Wallace. It included the five drug charges from the previous indictment and added two counts of perjury, in violation of 18 U.S.C. § 1621, based on Wallace’s testimony at her trial. At a status conference on April 5, 2007 before the district judge, Wallace and her counsel specifically stated that they had discussed making a motion to sever the perjury and drug charges. Wallace stated that she understood that she could ask to separate the perjury and drug charges, but she wanted to try all counts together. The second trial began on May 15, 2007, and the drug and perjury charges were tried together. Defendant filed a motion for acquittal pursuant to Rule 29 of Federal Rules of Criminal Procedure that was denied. The jury convicted her of all counts. Wallace was sentenced to seventy-eight months in prison. She timely filed an appeal of both the conviction and the sentence.

DISCUSSION

I. Joinder of Drug and Perjury Charges.

Defendant’s first argument challenging her conviction is that the joinder of [798]*798the drug and perjury charges was improper. It is unclear from Defendant’s briefing whether she challenges the indictment itself as improper or the actual joinder at trial, nor is it clear that the analysis would be different based on which of those two things Wallace was actually challenging. No matter what she is challenging, the verdict must stand because Defendant waived her right to separate trials on the drug and perjury counts and has suffered no constitutional harm as a result of all charges being tried together in a single trial. Defendant admits that she did not object to the joinder of the drug and perjury charges pursuant to Federal Rule of Criminal Procedure 14. Under Federal Rule of Criminal Procedure 12(b)(3), a Rule 14 motion to sever charges must be raised before trial. Under Rule 12(e), any Rule 12(b)(3) objection is waived if not made in the allotted time prior to trial. A court may grant relief from the waiver “for good cause.” Fed.R.Crim.P. 12

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Daniel Gwin
Sixth Circuit, 2024
United States v. Daniela Gozes-Wagner
977 F.3d 323 (Fifth Circuit, 2020)
United States v. Ediberto Aguilar-Calvo
945 F.3d 464 (Sixth Circuit, 2019)
United States v. Richard Parrish
915 F.3d 1043 (Sixth Circuit, 2019)
United States v. Fontrise Charles
702 F. App'x 288 (Sixth Circuit, 2017)
United States v. Chad Pyles
862 F.3d 82 (D.C. Circuit, 2017)
United States v. Charles Gahan
678 F. App'x 275 (Sixth Circuit, 2017)
United States v. Berryon Moore, III
654 F. App'x 705 (Sixth Circuit, 2016)
United States v. Rodney Henry
819 F.3d 856 (Sixth Circuit, 2016)
United States v. Michael Thoran
819 F.3d 298 (Sixth Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
597 F.3d 794, 2010 U.S. App. LEXIS 5357, 2010 WL 910103, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-wallace-ca6-2010.